Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials

Published:2018-02-01 Issue:10 Volume:217 Page:1616-1625
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Beran Jiři¹,Lickliter Jason D²,Schwarz Tino F³,Johnson Casey⁴,Chu Laurence⁵,Domachowske Joseph B⁶,Van Damme Pierre⁷,Withanage Kanchanamala⁷,Fissette Laurence A⁸,David Marie-Pierre⁸,Maleux Koen⁹,Schmidt Alexander C¹⁰,Picciolato Marta¹¹,Dieussaert Ilse¹²

Affiliation:

1. Vaccination and Travel Medicine Centre, Hradec Králové, Czech Republic

2. Nucleus Network, Melbourne, Australia

3. Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany

4. Johnson County Clinic Trials, Lenexa, Kansas

5. Benchmark Research, Austin, Texas

6. Department of Pediatrics, SUNY Upstate Medical Center, Syracuse, New York

7. Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp

8. Biostatistics, Biostat, and Stat Programming

9. CLS/CIAM

10. Clinical Research and Development, GSK, Rockville, Maryland, USA

11. Clinical Research and Development, GSK, Rixensart, Belgium

12. Research and Development, GSK, Rockville, Maryland, USA

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/10/1616/25090132/jiy065.pdf

Reference17 articles.

1. Respiratory syncytial virus and parainfluenza virus;Hall;N Engl J Med,2001

2. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006;Stockman;Pediatr Infect Dis J,2012

3. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area;Deshpande;Arch Dis Child,2003

4. Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK;Taylor;BMJ Open,2016

5. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique;Roca;J Med Virol,2002

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis;BMC Public Health;2024-05-06

2. Clinical research on RSV prevention in children and pregnant women: progress and perspectives;Frontiers in Immunology;2024-01-24

3. Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models;npj Vaccines;2023-09-29

4. RBF Protein with MA103 Adjuvant Elicited Protective Immunity against Human Respiratory Syncytial Virus in BALB/c Mice;Japanese Journal of Infectious Diseases;2023-05-31

5. Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized, observer-blind clinical trial;Respiratory Investigation;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3